NO20050290L - Nye tetrahydropyridin-derivater som renin-inhibitorer - Google Patents
Nye tetrahydropyridin-derivater som renin-inhibitorerInfo
- Publication number
- NO20050290L NO20050290L NO20050290A NO20050290A NO20050290L NO 20050290 L NO20050290 L NO 20050290L NO 20050290 A NO20050290 A NO 20050290A NO 20050290 A NO20050290 A NO 20050290A NO 20050290 L NO20050290 L NO 20050290L
- Authority
- NO
- Norway
- Prior art keywords
- renin inhibitors
- tetrahydropyridine derivatives
- novel
- novel tetrahydropyridine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0207102 | 2002-06-27 | ||
PCT/EP2003/004445 WO2004002957A1 (en) | 2002-06-27 | 2003-04-29 | Novel tetrahydropyridine derivatives as renin inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050290L true NO20050290L (no) | 2005-01-19 |
Family
ID=29797098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050290A NO20050290L (no) | 2002-06-27 | 2005-01-19 | Nye tetrahydropyridin-derivater som renin-inhibitorer |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060009497A1 (de) |
EP (1) | EP1519920A1 (de) |
JP (1) | JP2005532371A (de) |
CN (1) | CN1662498A (de) |
AU (1) | AU2003229746A1 (de) |
BR (1) | BR0312000A (de) |
CA (1) | CA2490138A1 (de) |
CL (1) | CL2003002043A1 (de) |
IL (1) | IL165887A0 (de) |
MX (1) | MXPA04012136A (de) |
NO (1) | NO20050290L (de) |
PL (1) | PL375214A1 (de) |
RU (1) | RU2005102002A (de) |
TW (1) | TW200514772A (de) |
WO (1) | WO2004002957A1 (de) |
ZA (1) | ZA200408423B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1780836A (zh) * | 2003-04-28 | 2006-05-31 | 埃科特莱茵药品有限公司 | 作为血管紧张肽原酶抑制剂的新型二氮杂双环壬烯和四氢吡啶衍生物 |
CA2521932A1 (en) * | 2003-04-29 | 2004-11-11 | Actelion Pharmaceuticals Ltd | Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives |
CN1780663A (zh) * | 2003-04-30 | 2006-05-31 | 埃科特莱茵药品有限公司 | 作为肾素抑制剂的新型3-位具有杂原子的9-氮杂双环壬烯衍生物 |
AU2004233577A1 (en) * | 2003-05-02 | 2004-11-11 | Actelion Pharmaceuticals Ltd. | Diazabicyclononene derivatives |
WO2004105738A2 (en) * | 2003-05-30 | 2004-12-09 | Actelion Pharmaceuticals Ltd | Use of tetrahydropyridine derivatives |
JP2007508260A (ja) * | 2003-10-09 | 2007-04-05 | アクテリオン ファマシューティカルズ リミテッド | 新規なテトラヒドロピリジン誘導体 |
CN1867568A (zh) * | 2003-10-13 | 2006-11-22 | 埃科特莱茵药品有限公司 | 二氮杂二环壬烯衍生物及其作为血管紧张肽原酶抑制剂的用途 |
US20070111989A1 (en) * | 2003-12-05 | 2007-05-17 | Olivier Bezencon | Novel diazabicyclononene derivatives and use |
EP1705176A4 (de) * | 2004-01-14 | 2009-06-03 | Takeda Pharmaceutical | Carbonsäureamidderivat und dessen anwendung |
EP1729749A2 (de) * | 2004-03-17 | 2006-12-13 | Novartis AG | Verwendung von renininhibitoren in therapie |
AU2005276624B2 (en) | 2004-08-25 | 2011-09-29 | Actelion Pharmaceuticals Ltd. | Bicyclononene derivatives as renin inhibitors |
GB0428526D0 (en) * | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
GB0500784D0 (en) * | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
GB0504850D0 (en) * | 2005-03-09 | 2005-04-13 | Novartis Ag | Organic compounds |
GB0510810D0 (en) * | 2005-05-26 | 2005-06-29 | Novartis Ag | Organic compounds |
NZ564689A (en) | 2005-05-27 | 2011-02-25 | Actelion Pharmaceuticals Ltd | Novel piperidine carboxylic acid amide derivatives |
GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
WO2007049224A1 (en) * | 2005-10-25 | 2007-05-03 | Actelion Pharmaceuticals Ltd | Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives |
JP2009526767A (ja) | 2006-02-02 | 2009-07-23 | アクテリオン ファーマシューティカルズ リミテッド | 新規二級アミン |
CN101395135A (zh) * | 2006-03-03 | 2009-03-25 | 埃科特莱茵药品有限公司 | 新颖的一级胺化物 |
AR059886A1 (es) * | 2006-03-08 | 2008-05-07 | Actelion Pharmaceuticals Ltd | Derivados de amidas como inhibidores de renina |
EP1908471A1 (de) * | 2006-10-04 | 2008-04-09 | Speedel Experimenta AG | Tetrahydropyridine als Renin Inhibitoren |
EP2162436A4 (de) | 2007-05-24 | 2010-08-04 | Merck Frosst Canada Ltd | Neuer fall von renininhibitoren |
US8334308B2 (en) | 2007-08-20 | 2012-12-18 | Merck Sharp & Dohme Corp. | Renin inhibitors |
JP4790871B2 (ja) | 2008-05-05 | 2011-10-12 | メルク フロスト カナダ リミテツド | レニン阻害剤としての3,4−置換ピペリジン誘導体 |
CA2936749C (en) | 2010-06-11 | 2019-07-09 | Joshua R. Giguere | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
TWI471289B (zh) | 2010-06-11 | 2015-02-01 | Rhodes Technologies | 使三級胺進行n-脫烷反應之方法 |
CN117865941A (zh) * | 2024-03-13 | 2024-04-12 | 上海方予健康医药科技有限公司 | 取代哌啶化合物及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376666A (en) * | 1992-11-30 | 1994-12-27 | The Du Pont Merck Pharmaceutical Company | Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl |
ATE242213T1 (de) * | 1995-09-07 | 2003-06-15 | Hoffmann La Roche | Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz |
US6376672B1 (en) * | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
-
2003
- 2003-04-29 US US10/514,164 patent/US20060009497A1/en not_active Abandoned
- 2003-04-29 CN CN038138875A patent/CN1662498A/zh active Pending
- 2003-04-29 AU AU2003229746A patent/AU2003229746A1/en not_active Abandoned
- 2003-04-29 WO PCT/EP2003/004445 patent/WO2004002957A1/en active Application Filing
- 2003-04-29 JP JP2004516551A patent/JP2005532371A/ja active Pending
- 2003-04-29 MX MXPA04012136A patent/MXPA04012136A/es unknown
- 2003-04-29 BR BR0312000-7A patent/BR0312000A/pt not_active IP Right Cessation
- 2003-04-29 PL PL03375214A patent/PL375214A1/xx not_active Application Discontinuation
- 2003-04-29 CA CA002490138A patent/CA2490138A1/en not_active Abandoned
- 2003-04-29 EP EP03722566A patent/EP1519920A1/de not_active Withdrawn
- 2003-04-29 RU RU2005102002/04A patent/RU2005102002A/ru not_active Application Discontinuation
- 2003-10-10 CL CL200302043A patent/CL2003002043A1/es unknown
- 2003-10-28 TW TW092129927A patent/TW200514772A/zh unknown
-
2004
- 2004-10-18 ZA ZA200408423A patent/ZA200408423B/xx unknown
- 2004-12-21 IL IL16588704A patent/IL165887A0/xx unknown
-
2005
- 2005-01-19 NO NO20050290A patent/NO20050290L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2005532371A (ja) | 2005-10-27 |
RU2005102002A (ru) | 2005-09-20 |
US20060009497A1 (en) | 2006-01-12 |
PL375214A1 (en) | 2005-11-28 |
IL165887A0 (en) | 2006-01-15 |
TW200514772A (en) | 2005-05-01 |
CN1662498A (zh) | 2005-08-31 |
EP1519920A1 (de) | 2005-04-06 |
AU2003229746A1 (en) | 2004-01-19 |
CA2490138A1 (en) | 2004-01-08 |
WO2004002957A1 (en) | 2004-01-08 |
ZA200408423B (en) | 2005-10-11 |
BR0312000A (pt) | 2005-03-22 |
CL2003002043A1 (es) | 2005-01-28 |
MXPA04012136A (es) | 2005-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050290L (no) | Nye tetrahydropyridin-derivater som renin-inhibitorer | |
NO20055623L (no) | Azabicyklononenderivater | |
NO20050932L (no) | 1-pyridin-4-yl-ureaderivater | |
NO20054974L (no) | 9-azabicyklo(3.3.1)non-6-en derivater med et heteroatom i 3-posisjonen som renin inhibitorer | |
NO20055624L (no) | Tropanderivater og deres anvendelse som Ace-inhibitorer | |
NO20061395L (no) | Nye pyridinderivater | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
NO20064584L (no) | Tetrahydropyridoindolderivater | |
NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
NO20031331L (no) | Substituerte amino-aza-cykloalkaner anvendelige mot malaria | |
NO20050668L (no) | 7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
NO20084186L (no) | Nye aminer | |
NO20076448L (no) | Novel piperidine carboxylic acid amide derivatives | |
DK1246809T3 (da) | 5-aryl-1H-1,2,4-triazolforbindelser som inhibitor for cyclooxygenase-2 og farmaceutiske sammensætninger som indeholder dem | |
TW200621773A (en) | Bicyclononene derivatives | |
NO20083738L (no) | Sekundaere aminer som renininhibitorer | |
TW200628468A (en) | Bicyclononene derivatives | |
WO2005054244A3 (en) | Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain | |
NO20084055L (no) | Nye primaere aminer | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
DK1307445T3 (da) | Benzofuranderivater og deres anvendelse som antibakterielle midler | |
TW200621774A (en) | Bicyclononene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |